AmraysBio

Bengaluru, India Founded: 2019 • Age: 7 yrs
Amrays Bio innovates in bio sector with website updates and user engagement.

About AmraysBio

AmraysBio was a Healthcare company based in Bengaluru (India) founded in 2019 by Kanhu Charan Mishra. It operates as an amrays Bio innovates in bio sector with website updates and user engagement. It operates on a D2C model. The company is recorded as dissolved. AmraysBio offers products and services including Email Subscription Service. Its focus areas include Health and Biotechnology, Bio Innovation, Digital Services and User Engagement. Its legal entity in India is Amrays Bioinnovation Private Limited (U74999KA2019PTC121439). Its competitors include Qkine, Core Biogenesis, Future Fields, KAICO and Protera and 5 more; 9 of its 10 listed competitors have raised funding.

Company details

Amrays Bio is a company dedicated to innovation in the bio industry, offering services like email sign-ups for updates and promotions. It operates a website that uses cookies to optimize user experience and analyze traffic, while adhering to privacy policies. The firm engages users through contact forms and protects content with standard terms. Based on available details, it serves clients interested in bio advancements, emphasizing digital interactions for better future solutions.

Key Metrics

Products & Services of AmraysBio

AmraysBio offers a comprehensive portfolio of products and services, including Email Subscription Service.

Email Subscription Service
Marketing Platform

Service for users to sign up and receive updates and promotions via email.

Funding Insights of AmraysBio

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of AmraysBio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jun 2019–Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in AmraysBio

AmraysBio has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Startup Karnataka.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Support for startups in Karnataka is delivered through policies, funding, and networking services.
2004missionstartupkarnataka.orgBengaluru, India
Premium access

Investor details for AmraysBio

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Amrays Bioinnovation Private Limited (AmraysBio)

Amrays Bioinnovation Private Limited is the primary company behind AmraysBio. The board of Amrays Bioinnovation Private Limited currently have 2 directors; the longest-serving is Kanhu Charan Mishra, appointed in 2019.

DirectorDesignationAppointedTenureEntity
Kanhu Charan Mishra
DIN 08362050
Director14 Feb 20197 yrs 8 moAmrays Bioinnovation Private Limited
Seema Mahapatra
DIN 08362051
Director14 Feb 20197 yrs 8 moAmrays Bioinnovation Private Limited

People of AmraysBio

1 people are tracked at AmraysBio (1 in leadership).

NameRoleGroup
FounderLeadership
Premium access

Complete people profiles for AmraysBio

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of AmraysBio

2 dated milestones of AmraysBio, from founding to its latest funding, stage changes and deals.

  1. Founded AmraysBio is founded.
  2. Funding First funding round.

Competitors of AmraysBio

AmraysBio has 10 listed competitors in our database, 9 of them funded. They include Qkine, Core Biogenesis, Future Fields, KAICO and Protera, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
qkine.com2016Cambridge, United Kingdom$8.15M15
Animal-free growth factors are developed for life science applications.
corebiogenesis.com2020Paris, France$14.12M–
UBaaS platform for plant-based recombinant protein bioproduction is offered.
futurefields.io2017Edmonton, Canada$21.55M28
Serum-free bioactive growth factors and recombinant proteins are biomanufactured.
kaicoltd.jp2018Fukuoka, Japan$4.37M–
Manufacturer of portfolio of proteins and other biological cytokines and enzymes
proterabio.com2018Sunnyvale, United States$15.85M–
Protein-based enzyme technologies are developed using deep learning algorithms.
algenex.com2005Madrid, Spain$13.28M–
Developer of recombinant biologics for animal and human health
klotho.com2016San Diego, United States$10M–
Patent-pending klotho protein technology is developed for anti-aging applications.
icongenetics.com1999Halle, Germany$14.6M25
Biopharmaceuticals and proteins are developed using green plants as hosts.
xiasbio.com2020United States$250,000–
Developer of recombinant proteins
jlandbiotech.com2015Taizhou, China––
Recombinant proteins are developed for biomedical applications.
Premium access

Detailed competitors of AmraysBio

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

10 companies that operate in the same segment as AmraysBio (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M––
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B–1,111
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.34 BUSD 301.49 M1,372
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Biological reagents and antibodies are developed for life science research.
1998Cambridge, Cambridgeshire, United KingdomUSD 78.8 M––
Electron microscopy services and microanalysis instruments are provided.
1956Waltham, Massachusetts, United States–USD 44.56 B125,000
Novel therapeutics are discovered using an AI-enabled drug platform.
2013New York, New York, United StatesUSD 456.66 MUSD 74.68 M–
A platform for sharing and accessing academic research papers is provided.
2008San Francisco, California, United StatesUSD 58.4 M––
Developer of molecular diagnostic testing solutions
1996Sunnyvale, California, United StatesUSD 19.1 MUSD 54.88 M208
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about AmraysBio

AmraysBio was founded in 2019.

AmraysBio is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Amrays Bio is a company dedicated to innovation in the bio industry, offering services like email sign-ups for updates and promotions. It operates a website that uses cookies to optimize user experience and analyze traffic, while adhering to privacy policies. The firm engages users through contact forms and protects content with standard terms. Based on available details, it serves clients interested in bio advancements, emphasizing digital interactions for better future solutions.

AmraysBio's top competitors include Future Fields, Qkine and Core Biogenesis.

AmraysBio offers Email Subscription Service.

AmraysBio has 1 investor. Key investors include Startup Karnataka.

AmraysBio operates through Amrays Bioinnovation Private Limited.

The legal entities of AmraysBio currently have 2 directors, including Kanhu Charan Mishra, Seema Mahapatra.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available